Brind.

Stifel reiterated a Buy rating on Incyte.

1 report, 1 independent Updated Jun 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Stifel reiterated a Buy rating on Incyte.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Incyte

    American pharmaceutical company

    Nothing else this week.

  • Stifel

    American investment bank

    Nothing else this week.

Coverage

Newest first; wire copies grouped